Development of Tissue-Targeting Hemagglutinating Virus of Japan Envelope Vector for Successful Delivery of Therapeutic Gene to Mouse Skin-Reference-Cited by-同舟云学术

Development of Tissue-Targeting Hemagglutinating Virus of Japan Envelope Vector for Successful Delivery of Therapeutic Gene to Mouse Skin

Published:2007-10 Issue:10 Volume:18 Page:881-894
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Kawachi Masako¹,Tamai Katsuto¹,Saga Kotaro¹,Yamazaki Takehiko¹,Fujita Hiroshi¹,Shimbo Takashi¹,Kikuchi Yasushi¹,Nimura Keisuke¹,Nishifuji Koji²,Amagai Masayuki²,Uitto Jouni³,Kaneda Yasufumi¹

Affiliation:

1. Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.

2. Department of Dermatology, School of Medicine, Keio University, Shinjuku, Tokyo 160-8532, Japan.

3. Department of Dermatology and Cutaneous Biology, Jefferson Medical College, and Jefferson Institute of Molecular Medicine, Thomas Jefferson University, Philadelphia, PA 19107.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2007.046

Reference28 articles.

1. Assembly of Sendai Virus: M Protein Interacts with F and HN Proteins and with the Cytoplasmic Tail and Transmembrane Domain of F Protein

2. Surface distribution and recycling of the low density lipoprotein receptor as visualized with antireceptor antibodies.

3. Biology of anchoring fibrils: lessons from dystrophic epidermolysis bullosa

4. Type VII Collagen, Anchoring Fibrils, and Epidermolysis Bullosa

5. Current Advances and Future Challenges in Adenoviral Vector Biology and Targeting

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer immunotherapy using the Fusion gene of Sendai virus;Cancer Gene Therapy;2019-08-06

2. Establishment of integration-free induced pluripotent stem cells from human recessive dystrophic epidermolysis bullosa keratinocytes;Journal of Dermatological Science;2018-03

3. Multi-modal Anti-cancer Activities Provided by a Non-replicating Sendai Virus Envelope;Current Cancer Therapy Reviews;2016-02-02

4. Oncolytic Sendai virus-based virotherapy for cancer: recent advances;Oncolytic Virotherapy;2015-10

5. Membrane Fusion Mediated Targeted Cytosolic Drug Delivery Through scFv Engineered Sendai Viral Envelopes;Current Molecular Medicine;2015-05-27